← back to search

Adrienne A. Phillips

Cornell University · US
Area of research
Hematology · Immunology
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, T-cell and Retrovirus Studies, Lymphoma Diagnosis and Treatment, and Vector-Borne Animal Diseases.
h-index
22
citations
1,477
works
122
NIH funding
primary concept
Medicine
email

Recent publications

ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma
Transplantation and Cellular Therapy 2023cited by 38position: middledoi
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells
Cancer Research 2023cited by 25position: middledoi
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients
Clinical Infectious Diseases 2021cited by 54position: middledoi
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma–type Richter syndrome
Blood Advances 2021cited by 53position: middledoi
How I treat adult T-cell leukemia/lymphoma
Blood 2020cited by 79position: lastdoi
Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report
Journal of Clinical Oncology 2019cited by 257position: middledoi
Mogamulizumab <i>versus</i> investigator’s choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma
Haematologica 2018cited by 68position: firstdoi
Health Disparities and the Global Landscape of Lymphoma Care Today
American Society of Clinical Oncology Educational Book 2017cited by 31position: firstdoi
Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma
Blood Cancer Journal 2016cited by 38position: middledoi
A prospective, multicenter, randomized study of anti-CCR4 monoclonal antibody mogamulizumab (moga) vs investigator's choice (IC) in the treatment of patients (pts) with relapsed/refractory (R/R) adult T-cell leukemia-lymphoma (ATL).
Journal of Clinical Oncology 2016cited by 11position: firstdoi
A Prospective, Multicenter, Randomized Study of Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Investigator's Choice in the Treatment of Patients with Relapsed/Refractory Adult T-Cell Leukemia-Lymphoma: Overall Response Rate, Progression-Free Survival, and Overall Survival
Blood 2016cited by 10position: firstdoi
Incidence and survival patterns of cutaneous T-cell lymphomas in the United States
Leukemia & lymphoma/Leukemia and lymphoma 2012cited by 132position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Juan Carlos Ramos · Hospital Universitario La Paz4 papers (2016–2018) · 3 papers (2016–2018)Olivier Hermine · Institut de Biologie Moléculaire et Cellulaire3 papers (2016–2018)Karen M. Dwyer · The Ohio State University Wexner Medical Center3 papers (2016–2018)Steven M. Horwitz · Weill Cornell Medicine3 papers (2016–2018)Lucy Cook · Imperial College Healthcare NHS Trust3 papers (2016–2020) · 3 papers (2016–2018) · 3 papers (2016–2018) · 3 papers (2016–2018)Kevin C. Conlon · Tallaght University Hospital3 papers (2016–2018)Graham P. Taylor · NIHR Biomedical Research Centre at The Royal Marsden and the ICR3 papers (2016–2018)Farooq Wandroo · University of Birmingham2 papers (2016–2018)Jingmei Hsu · Taipei Medical University2 papers (2021–2023)Sebastian Mayer · Cornell University2 papers (2021–2023)Mollie Leoni · Kura Oncology (United States)2 papers (2016–2018)Paul Fields · Tempus Labs (United States)2 papers (2016–2018)Ahmed Sawas · Columbia University2 papers (2016–2018)Carlos Brites · Universidade Federal da Bahia2 papers (2016–2016) · 2 papers (2016–2016)Tatyana Feldman · Hackensack University Medical Center2 papers (2016–2018)